16 related articles for article (PubMed ID: 38498979)
1. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release.
Ganapathy K; Datta I; Sowmithra S; Joshi P; Bhonde R
J Cell Biochem; 2016 Dec; 117(12):2719-2736. PubMed ID: 27064513
[TBL] [Abstract][Full Text] [Related]
2. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
[TBL] [Abstract][Full Text] [Related]
3. Tocotrienols protect differentiated SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cytotoxicity by ameliorating dopamine biosynthesis and dopamine receptor D2 gene expression.
Magalingam KB; Somanath SD; Md S; Haleagrahara N; Fu JY; Selvaduray KR; Radhakrishnan AK
Nutr Res; 2022 Feb; 98():27-40. PubMed ID: 35065349
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway.
Tiong CX; Lu M; Bian JS
Br J Pharmacol; 2010 Sep; 161(2):467-80. PubMed ID: 20735429
[TBL] [Abstract][Full Text] [Related]
6.
El-Habta R; Af Bjerkén S; Virel A
Neurol Res; 2024 May; 46(5):406-415. PubMed ID: 38498979
[TBL] [Abstract][Full Text] [Related]
7. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]